The 90-day, randomized, double-blind, controlled study administered a daily dose of 500 mg of PACran.
Decas Botanical Synergies (Carver, MA) announced the publication of a study in Current Bioactive Compounds examining the effects of the company’s PACran cranberry supplement on women with recurring urinary tract infections (UTIs) and a confirmed presence of E. coli in the culture of urine samples.
The 90-day, randomized, double-blind, controlled study administered a daily dose of 500 mg of PACran. The company says that at the end of the treatment period, results showed a significant reduction in the presence of E. coli and support for urinary tract health.
Celebrating International Women's Day: Highlighting research on women's health and wellness, Part II
Published: March 7th 2025 | Updated: March 7th 2025To celebrate International Women's Day (March 8), Nutritional Outlook is putting the spotlight on women's health and wellness. In this compilation, we present recent research on pregnancy and menopause.
Celebrating International Women's Day: Highlighting research on women's health and wellness, part I
March 6th 2025To celebrate International Women's Day (March 8), Nutritional Outlook is putting the spotlight on women's health and wellness. In this compilation, we present recent research on menstruation and skin health.